FGF23 and chronic kidney disease: Results from our longitudinal data suggest that nephrocalcinosis contributes, at least in part, to the progression of CKD, as demonstrated by the significant increase in plasma concentrations of creatinine, phosphate and FGF23 over time in CKD cats with ultrasound‐diagnosed nephrocalcinosis at enrollment.